Clinicopathologic features of patients with non-small cell lung cancer harboring the EML4-ALK fusion gene: A meta-analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Wang, Ying ^a   Wang, Shumin ^b   Xu, Shiguang ^b   Qu, Jiaqi ^b   Liu, Bo ^b  

^a SHENYANG MEDICAL COLLEGE   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EML4-ALK FUSION PROTEIN, HUMAN; ONCOPROTEIN;

ADULT; ARTICLE; CLINICAL FEATURE; EML4 ALK GENE; FEMALE; FUSION GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HETEROZYGOTE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; SEX RATIO; SMOKING; WILD TYPE; GENETICS; LUNG TUMOR; META ANALYSIS; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; ONCOGENE PROTEINS, FUSION;

EID: 84910003700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110617     Document Type: Article

References (31)

1. Zimmermann S, Peters S (2012) Going beyond EGFR. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 23 Suppl 10: x197-203.
2. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, et al. (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566.
3. Soda M, Takada S, Takeuchi K, Choi YL, Enomoto M, et al. (2008) A mouse model for EML4-ALK-positive lung cancer. Proceedings of the National Academy of Sciences of the United States of America 105: 19893-19897.
4. Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G (2008) The anaplastic lymphoma kinase in the pathogenesis of cancer. Nature reviews Cancer 8: 11-23.
5. Zhang X, Zhang S, Yang X, Yang J, Zhou Q, et al. (2010) Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Molecular cancer 9: 188.
6. Li Y, Li Y, Yang T, Wei S, Wang J, et al. (2013) Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer. PloS one 8: e52093.
7. Shaw AT, Yeap BY, Mino-Kenudson M, Digumarthy SR, Costa DB, et al. (2009) Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27: 4247-4253.
8. Wong DW, Leung EL, So KK, Tam IY, Sihoe AD, et al. (2009) The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 115: 1723-1733.
9. Kobayashi M, Sakakibara T, Inoue A, Fukuhara T, Sasano H, et al. (2014) An effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer. Respiratory investigation 52: 49-56.
10. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151: 264-269.
11. Team RC (2014) R: A Language and Environment for Statistical Computing. Vienna; 2014.
12. Zhang YG, Jin ML, Li L, Zhao HY, Zeng X, et al. (2013) Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues. PloS one 8: e64821.
13. Wang Z, Zhang X, Bai H, Zhao J, Zhuo M, et al. (2012) EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer. Oncology 83: 248-256.
14. Takeda M, Okamoto I, Sakai K, Kawakami H, Nishio K, et al. (2012) Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 23: 2931-2936.
15. Takahashi T, Sonobe M, Kobayashi M, Yoshizawa A, Menju T, et al. (2010) Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene. Annals of surgical oncology 17: 889-897.
16. Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, et al. (2012) Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations. Genes, chromosomes & cancer 51: 925-932.
17. Martelli MP, Sozzi G, Hernandez L, Pettirossi V, Navarro A, et al. (2009) EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. American Journal of Pathology 174: 661-670.
18. Koivunen JP, Mermel C, Zejnullahu K, Murphy C, Lifshits E, et al. (2008) EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 14: 4275-4283.
19. Inamura K, Takeuchi K, Togashi Y, Nomura K, Ninomiya H, et al. (2008) EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 3: 13-17.
20. Fukui T, Yatabe Y, Kobayashi Y, Tomizawa K, Ito S, et al. (2012) Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene. Lung cancer (Amsterdam, Netherlands) 77: 319-325.
21. Tufman AL, Edelmann M, Gamarra F, Reu S, Borgmeier A, et al. (2014) Preselection based on clinical characteristics in german non-small-cell lung cancer patients screened for EML4-ALK translocation. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 9: 109-113.
22. Zhou JX, Yang H, Deng Q, Gu X, He P, et al. (2013) Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 24: 1319-1325.
23. Wang J, Cai Y, Dong Y, Nong J, Zhou L, et al. (2014) Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCR. PloS one 9: e101551.
24. Zhong S, Zhang HP, Zheng J, Bai DY, Fu L, et al. (2013) [Detection of EML4-ALK fusion gene in non-small cell lung cancer and its clinicopathologic correlation]. Zhonghua bing li xue za zhi Chinese journal of pathology 42: 252-256.
25. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, et al. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203.
26. Shinmura K, Kageyama S, Tao H, Bunai T, Suzuki M, et al. (2008) EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas. Lung cancer (Amsterdam, Netherlands) 61: 163-169.
27. Dietz PM, Homa D, England LJ, Burley K, Tong VT, et al. (2011) Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. American Journal of Epidemiology 173: 355-359.
28. Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. The Lancet 378: 1297-1305.
29. Yang G, Ma J, Liu N, Zhou L (2005) [Smoking and passive smoking in Chinese, 2002]. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi 26: 77-83.
30. Tsai YW, Tsai TI, Yang CL, Kuo KN (2008) Gender differences in smoking behaviors in an Asian population. Journal of Women's Health 17: 971-978.
31. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, et al. (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. The New England journal of medicine 363: 1693-1703.